Loading...
Wesana Health Holdings Inc.
WSNAF•PNK
HealthcareBiotechnology
$0.03
$0.003(9.04%)
Wesana Health Holdings Inc. (WSNAF) Stock Overview
Explore Wesana Health Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for WSNAFStats details for WSNAF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for WSNAFAnalyst Recommendations details for WSNAF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is based in Chicago, Illinois.
CEO
Mr. Daniel Carcillo
Employees
7
Headquarters
433 W Van Buren Street, Chicago, IL
Founded
2021